MedPath

Effects of intravenous caffeine on Fractional Flow Reserve measurements in coronary artery disease

Not Applicable
Completed
Conditions
Coronary artery disease
Ischaemic heart disease
Cardiovascular - Coronary heart disease
Registration Number
ACTRN12614000142639
Lead Sponsor
The Northern Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

Moderate coronary artery disease requiring FFR measurements.
FFR measurement <0.90
Valid consent

Exclusion Criteria

Inability to give informed consent
Caffeine contraindicated
Adenosine contraindicated

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Any statistical significant change FFR measurements after caffeine administration.[After completion of second FFR measurement.]
Secondary Outcome Measures
NameTimeMethod
Any clinically significant change in FFR measurements. (defined as crossing cutoff values of 0.80; i.e.: decrease in FFR above 0.80 to below 0.80) [After completion of second FFR measurement.]
© Copyright 2025. All Rights Reserved by MedPath